Myriad Genetics Inc (NASDAQ:MYGN)

27.84
Delayed Data
As of 4:00pm ET
 -0.60 / -2.11%
Today’s Change
9.24
Today|||52-Week Range
31.60
+40.78%
Year-to-Date

Today’s Trading

Previous close28.44
Today’s open28.24
Day’s range26.79 - 28.45
Volume42,900
Average volume (3 months)803,157
Market cap$2.3B
Data as of 4:00pm ET, 03/05/2021

Growth & Valuation

Earnings growth (last year)-4,389.30%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-24.97%
P/E ratioNM
Price/Sales1.32
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.60+3.25%
VCYTVeracyte Inc+0.73+1.56%
TRILTrillium Therapeutic...-0.19-1.86%
CLDXCelldex Therapeutics...+1.07+4.25%
Data as of 4:00pm ET, 03/05/2021

Financials

Next reporting dateNovember 9, 2021
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$638.6M
Annual profit (last year)-$199.5M
Net profit margin-31.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts